Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

한국 소아 내분비 및 대사질환의 역학

The prevalence of pediatric endocrine and metabolic diseases in Korea

  • 이동환 (순천향대학교 의과대학 소아과학교실)
  • Lee, Dong Hwan (Department of Pediatrics, College of Medicine, Soonchunhyang University)
  • 투고 : 2008.04.13
  • 심사 : 2008.05.08
  • 발행 : 2008.06.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The government neonatal screening program has a 17-years history. Therefore, it can now provide information on the prevalence of endocrine and metabolic diseases which included in neonatal screening. Knowledge of the prevalence of metabolic diseases is very important with these results, the most effective screening methods can be determined and diseases can be identified that should be added to neonatal screening. For these purposes regular follow-up of patients with metabolic diseases and quality assuarance are also needed.

키워드

참고문헌

  1. Lee DH. Neonatal screening for inborn errors of metabolism. J Korean Pediatr Soc 1987;30:9-16
  2. Lee DH. Neonatal screening test. J Korean Med Assoc 1994;37:1464-80
  3. Han YJ, Lee DH. Kim ES. Plans to improve the mass screening tests on inborn errors of metabolism in Korea. Korean public health and society research center in department of ministry of health and welfare in Korea 2000:51-68
  4. Lee DH, Choi TY, Jun BY, Kang JK. The analysis of the current status and improvement of neonatal screening test for prevention of mental retardation. Report of Health Promotion Fund 2004:1-167
  5. Choi TY. Analysis of blood sample records for neonatal screening test and external quality assessment for inborn errors of metabolism in Korea (2005). Ministry of health & welfare, Planned Population Federation of Korea
  6. Bickel H, Guthrie R, Hammersen G. Neonatal screening for inborn errors of metabolism. Springer-Verlag 1980:1-79
  7. Lee DH. Neonatal screening in Korea, In: New trends in neonatal screening. Hokkaido Univ. press 1994;3-5
  8. Statistical Book of Genetic & Rare Diseases. Korea Centers for Disease Control and Prevention. National Institute of Health. Korean Genetic & Rare Diseases Center 2006
  9. International Atomic Energy Agency. Screening of newborns for congenital hypothyroidism - Guidence for developing programmes. Vienna : IAEA 2005:13-7
  10. Abadie V, Berthoelot J, Feillet F, Maurin N, Mercier A, de Baulny HO, et al. Neonatal screening and long-term followup of phenylketonuria : the French database. Early Hum Dev 2001;6E5:149-58
  11. Gu XF, Wang ZG. Screening for phenylketonuria and congenital hypothyroidism in 5.8 million neonates in China. Zhonghua tu Fang Yi Xue Za Zhi 2004;38:99-102
  12. Jiang J, Ma X, Huang X, Pei X, Liu H, Tan Z, Zhu L. A survey for the incidence of phenylketonuria in Guangdong, China. Southeast Asian J Trop Med Public Health 2003;34 Suppl 3:185
  13. Al-Hosani H, Sarah M, Saade D, Osman H, Al-Zahid J. United Arab Emirates National Newborn Screening Programme : an evaluation 1998-2000. East editerr Health J 2003;9:324-32
  14. Pangkanon S, Ratrisawadi V, Charoensiriwatana W, Techasena W, Boonpuan K, Srisomsap C, et al. Phenylketonuria detected by the neonatal screening program in Thailand. Southeast Asian J Trop Med Public Health 2003;34 suppl 3:179-81
  15. Choi TY, Kim JW, Min WK, Song WH, Yoon HR, Lee K, et al. Analysis of blood sample records for neonatal screening test and external quality assessment for inborn errors of metabolism in Korea. J Korean Soc Matern Child Health 2003;7:7-17
  16. Choi TY, Lee DH. Results of neonatal screening test and prevalence at birth of phenylketonuria and congenital hypothyroidism for 15 years in Korea. J Korean Soc Inherit Metabolic Dis 2006;6:24-31
  17. Lee HJ. Inborn errors of metabolism in Korea. J Korean Neurol Assoc 2004;22:1-10
  18. Lee HJ. Organic acidemias in Korea. J Korean Pediatr Soc 2002;45:1459-76
  19. Yoon HR, Lee KR, Kang SW, Lee DH, Yoo HW, Min WK, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clinica Chimica Acta 2005;354:167-80 https://doi.org/10.1016/j.cccn.2004.11.032

피인용 문헌

  1. 14년간 신생아 선별검사에서 고메티오닌혈증으로 전원된 환아들의 임상적 고찰 vol.53, pp.3, 2010, https://doi.org/10.3345/kjp.2010.53.3.329
  2. Molecular and biochemical characterization of the GALT gene in Korean patients with galactose-1-phosphate uridyltransferase deficiency vol.411, pp.19, 2010, https://doi.org/10.1016/j.cca.2010.06.008
  3. Molecular screening of the TSH receptor (TSHR) and thyroid peroxidase (TPO) genes in Korean patients with nonsyndromic congenital hypothyroidism vol.75, pp.5, 2008, https://doi.org/10.1111/j.1365-2265.2011.04156.x
  4. 선천성 갑상선기능저하증과 가성부갑상선기능저하증을 동반한 환자의 전신마취 하 치과치료 vol.13, pp.3, 2008, https://doi.org/10.17245/jkdsa.2013.13.3.139
  5. Novel GALT variations and mutation spectrum in the Korean population with decreased galactose-1-phosphate uridyltransferase activity vol.15, pp.None, 2008, https://doi.org/10.1186/s12881-014-0094-5
  6. Identification of Two Novel BCKDHB Mutations in Korean Siblings with Maple Syrup Urine Disease Showing Mild Clinical Presentation vol.11, pp.1, 2008, https://doi.org/10.5734/jgm.2014.11.1.22
  7. Analysis of Major Factors Affecting False Positive Results in Neonatal Screening Test within 3 Days after Birth vol.30, pp.3, 2019, https://doi.org/10.14734/pn.2019.30.3.154